EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment

Tian Tian iD, Huimin Liu iD, Peiyan Liu iD, Shumin Ye iD, Yudi Wu iD, Jun Zhou iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/1172509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 10.07.2026. Verfasst von Tian Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Changzhou Medical Center, Nanjing Medical University, Changzhou City, China, njmu.edu.cn. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Fibroblasts. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblastic reticular cells (FRCs), as core stromal cells in secondary lymphoid tissues and the tumor immune microenvironment (TIME), undergo significant immunometabolic reprogramming, which regulates antitumor immune responses. This structured narrative review summarizes the immunometabolic reprogramming of FRCs across various cancers, emphasizing glucose metabolism, lipid remodeling, and amino acid metabolism in lung cancer, breast cancer, gastric cancer, lymphoma, head and neck tumors, and melanoma. Under hypoxia, nutrient stress, and inflammatory stimulation, FRCs enhance glycolysis, alter fatty acid synthesis/oxidation, and disrupt amino acid metabolism, leading to immunosuppressive metabolite secretion, cytokine profile changes, and the formation of immune niches. Understanding these cancer‐specific molecular mechanisms can inform targeted immunometabolic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsFibroblastsHumansMetabolic ReprogrammingAnimals

Stichwörter der Autor:innen

fibroblastic reticular cellimmunometabolic reprogrammingmultiple cancer typestumor immune microenvironment

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Changzhou Medical Center, Nanjing Medical University, Changzhou City, China, njmu.edu.cn.
  • Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Changzhou, Changzhou City, China.

ORCID-Profile: Tian Tian, Huimin Liu, Peiyan Liu, Shumin Ye, Yudi Wu, Jun Zhou

Förderung

  • Changzhou Municipal Science and Technology Bureau

Zitieren

APA

Tian, T., Liu, H., Liu, P., Ye, S., Wu, Y., & Zhou, J. (2026). Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/1172509

Vancouver

Tian T, Liu H, Liu P, Ye S, Wu Y, Zhou J. Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/1172509

BibTeX
@article{Tian2026,
  author = {Tian, Tian and Liu, Huimin and Liu, Peiyan and Ye, Shumin and Wu, Yudi and Zhou, Jun},
  title = {Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/1172509}
}
Kostenlos starten →